Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterizing Rate of Progression in USHer Syndrome (CRUSH) Study

NCT04820244 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04820244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04820244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterizing Rate of Progression in USHer Syndrome (CRUSH) Study
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
February 11, 2019
Completion date
March 2, 2024
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa, ush2a, usher syndrome, type 2a